Millennium Management’s Ocata Therapeutics OCAT Stock Holding History
Bought
Maintained
Sold
Millennium Management's OCAT Position: Q1 2016 in Review
Millennium Management sold out of Ocata Therapeutics (OCAT) in Q1 2016, closing a stake of 12,600 shares — an estimated $106K sold.
Millennium Management first reported a position in OCAT in Q1 2015 and held it in 2 quarters. The position peaked at $319K in Q1 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.
- Millennium Management reported no remaining Ocata Therapeutics position as of Q1 2016 after selling out during the quarter.
- Millennium Management sold 12,600 Ocata Therapeutics shares in Q1 2016, an estimated $106K.
- Millennium Management first reported a position in Ocata Therapeutics in Q1 2015 and held it in 2 quarters.
- Millennium Management's Ocata Therapeutics position peaked at $319K in Q1 2015.
- 1 fund tracked by Wall St. Rank held Ocata Therapeutics as of Q1 2016.
Based on Millennium Management's 13F filing for Q1 2016, filed 16 May 2016.